InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Jacobs Bruce N., Chief Financial Officer. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 14 disclosures have been logged. The latest transaction was filed on 3 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
€39,51220,000 shares@ €1.97560.0006% mcap25.2% of flow
Common Stock
SEC:0000899243-22-016429:0·
013,300 shares0
Common Stock
SEC:0000899243-22-009078:0·
€27,44915,000 shares@ €1.82990.0004% mcap23.4% of flow
Common Stock
SEC:0000899243-22-002010·
€18,15510,000 shares@ €1.81550.0003% mcap15.5% of flow
Common Stock
SEC:0000899243-22-002016·
€27,44915,000 shares@ €1.82990.0004% mcap17.5% of flow
Common Stock
SEC:0000899243-22-002010:0·
€18,15510,000 shares@ €1.81550.0003% mcap11.6% of flow
Common Stock
SEC:0000899243-22-002016:0·
€18,39710,000 shares@ €1.83970.0003% mcap15.7% of flow
Common Stock
SEC:0000899243-21-046845·
€18,39710,000 shares@ €1.83970.0003% mcap11.7% of flow
Common Stock
SEC:0000899243-21-046845:0·
€18,50210,000 shares@ €1.85020.0003% mcap15.8% of flow
Common Stock
SEC:0000899243-21-045803·
€18,50210,000 shares@ €1.85020.0003% mcap11.8% of flow
Common Stock
SEC:0000899243-21-045803:0·
€17,51410,000 shares@ €1.75140.0003% mcap14.9% of flow
Common Stock
SEC:0000899243-21-035158·
€17,51410,000 shares@ €1.75140.0003% mcap11.2% of flow
Common Stock
SEC:0000899243-21-035158:0·
€17,14310,000 shares@ €1.71430.0003% mcap14.6% of flow
Common Stock
SEC:0000899243-21-022025·
€17,14310,000 shares@ €1.71430.0003% mcap10.9% of flow
Common Stock
SEC:0000899243-21-022025:0·
14 of 14 declarations
About Jacobs Bruce N.
Bruce N. Jacobs is the Chief Financial Officer of Kymera Therapeutics, Inc. He is responsible for the financial management of the company, including budgeting and financial performance analysis. His role is essential in ensuring Kymera's financial health and supporting its strategic initiatives. Bruce also contributes to the development of the company's overall financial strategy.
